Event dossier

For diabetes patients, stopping GLP-1 drugs linked to doubled risk of heart attack, stroke, death

People with type 2 diabetes who stopped GLP-1 treatment had twice the risk of heart attack, stroke or death than those who continued, according to a new study. Grouped from 2 articles across 2 sources.

2 reports2 sourcesNov 11, 2026, 6:13 AM
FilterEuronews
Clustered coverageCNBC, Euronews
Coverage timeline2
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

EuronewsNov 11, 2026, 6:13 AM

For diabetes patients, stopping GLP-1 drugs linked to doubled risk of heart attack, stroke, death

People with type 2 diabetes who stopped GLP-1 treatment had twice the risk of heart attack, stroke or death than those who continued, according to a new study.

CNBCNov 10, 2026, 11:03 PM

FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.